Thank you for your continued support and interest in InBody research. Today, more than 7,000 studies utilizing InBody have been published worldwide.
To keep you informed of the latest academic developments, we are offering a curated selection of recent publications through our monthly newsletter.
If you have any questions about the research or would like to request a device demonstration, please feel free to reply to this email.
Nutritional management for hospitalized and surgical patients is essential for minimizing complications and improving treatment outcomes, and its importance is widely recognized in clinical practice.
In Korea, Serum Albumin is the most commonly used parameter for evaluating nutritional status, and accordingly, it is used as a reimbursement criterion for intensive nutritional therapy under the national healthcare system.
However, concerns have been raised among international clinical nutrition experts about the appropriateness of relying solely on albumin levels for malnutrition diagnosis. (Jensen et al., 2024)
However, the validity of using serum albumin as the sole indicator for diagnosing malnutrition has been questioned by global clinical nutrition experts. (Jensen et al., 2024)
In response, representatives of four major global clinical nutrition societies—ASPEN, ESPEN, FELANPE, and PENSA—collaborated in September 2018 to establish the Global Leadership Initiative on Malnutrition (GLIM) criteria. Numerous recent studies have demonstrated that ㅡMuscle Mass evaluation is essential for accurate nutritional assessment. In line with this shift, countries such as Japan and France are at the forefront of a growing global trend to use muscle mass as a principal marker in nutritional evaluation.
This issue focuses on understanding muscle mass evaluation under the GLIM Guidance and its importance in guiding clinical nutritional decisions.
<aside> 💡
목차